CORTEX PHARMACEUTIC Price Prediction
| PHXDelisted Stock | USD 4.35 0.00 0.00% |
Momentum 62
Buy Extended
Oversold | Overbought |
Using CORTEX PHARMACEUTIC hype-based prediction, you can estimate the value of CORTEX PHARMACEUTIC from the perspective of CORTEX PHARMACEUTIC response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in CORTEX PHARMACEUTIC to buy its stock at a price that has no basis in reality. In that case, they are not buying CORTEX because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
CORTEX PHARMACEUTIC after-hype prediction price | EUR 4.35 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
CORTEX |
CORTEX PHARMACEUTIC After-Hype Price Prediction Density Analysis
As far as predicting the price of CORTEX PHARMACEUTIC at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in CORTEX PHARMACEUTIC or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of CORTEX PHARMACEUTIC, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
CORTEX PHARMACEUTIC Estimiated After-Hype Price Volatility
In the context of predicting CORTEX PHARMACEUTIC's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CORTEX PHARMACEUTIC's historical news coverage. CORTEX PHARMACEUTIC's after-hype downside and upside margins for the prediction period are 0.81 and 7.89, respectively. We have considered CORTEX PHARMACEUTIC's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
CORTEX PHARMACEUTIC is unstable at this time. Analysis and calculation of next after-hype price of CORTEX PHARMACEUTIC is based on 3 months time horizon.
CORTEX PHARMACEUTIC Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as CORTEX PHARMACEUTIC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CORTEX PHARMACEUTIC backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CORTEX PHARMACEUTIC, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.30 | 3.54 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4.35 | 4.35 | 0.00 |
|
CORTEX PHARMACEUTIC Hype Timeline
CORTEX PHARMACEUTIC is at this time traded for 4.35on Munich Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. CORTEX is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.3%. %. The volatility of related hype on CORTEX PHARMACEUTIC is about 0.0%, with the expected price after the next announcement by competition of 4.35. About 15.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.31. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. CORTEX PHARMACEUTIC last dividend was issued on the 20th of May 2025. The entity had 2:1 split on the 9th of October 2014. Considering the 90-day investment horizon the next forecasted press release will be within a week. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.CORTEX PHARMACEUTIC Related Hype Analysis
Having access to credible news sources related to CORTEX PHARMACEUTIC's direct competition is more important than ever and may enhance your ability to predict CORTEX PHARMACEUTIC's future price movements. Getting to know how CORTEX PHARMACEUTIC's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how CORTEX PHARMACEUTIC may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EPSN | Epsilon Energy | 0.00 | 0 per month | 0.00 | (0.19) | 2.78 | (4.00) | 11.90 | |
| PNRG | PrimeEnergy | 0.00 | 0 per month | 3.87 | (0.02) | 5.17 | (5.27) | 19.61 | |
| CRGY | Crescent Energy Co | 0.00 | 0 per month | 2.63 | (0.02) | 5.36 | (4.58) | 11.64 | |
| EPM | Evolution Petroleum | 0.00 | 0 per month | 1.72 | 0.05 | 3.06 | (3.14) | 8.70 | |
| BRN | Barnwell Industries | 0.00 | 0 per month | 0.00 | (0.04) | 7.03 | (4.84) | 56.04 | |
| MXC | Mexco Energy | 0.00 | 0 per month | 3.80 | 0.05 | 6.98 | (7.74) | 54.80 |
CORTEX PHARMACEUTIC Additional Predictive Modules
Most predictive techniques to examine CORTEX price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CORTEX using various technical indicators. When you analyze CORTEX charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About CORTEX PHARMACEUTIC Predictive Indicators
The successful prediction of CORTEX PHARMACEUTIC stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as CORTEX PHARMACEUTIC, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of CORTEX PHARMACEUTIC based on analysis of CORTEX PHARMACEUTIC hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to CORTEX PHARMACEUTIC's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CORTEX PHARMACEUTIC's related companies.
Story Coverage note for CORTEX PHARMACEUTIC
The number of cover stories for CORTEX PHARMACEUTIC depends on current market conditions and CORTEX PHARMACEUTIC's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that CORTEX PHARMACEUTIC is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about CORTEX PHARMACEUTIC's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
CORTEX PHARMACEUTIC Short Properties
CORTEX PHARMACEUTIC's future price predictability will typically decrease when CORTEX PHARMACEUTIC's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of CORTEX PHARMACEUTIC often depends not only on the future outlook of the potential CORTEX PHARMACEUTIC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CORTEX PHARMACEUTIC's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 37.5 M | |
| Cash And Short Term Investments | 2.2 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in CORTEX Stock
If you are still planning to invest in CORTEX PHARMACEUTIC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CORTEX PHARMACEUTIC's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |